Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.62
+0.83 (4.94%)
Aug 14, 2025, 2:15 PM - Market open
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.19 billion as of August 14, 2025. Its market cap has increased by 25.75% in one year.
Market Cap
1.19B
Enterprise Value
1.03B
1-Year Change
25.75%
Ranking
Category
Stock Price
$17.62
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.19B, an increase of 2,162.29%. That is a compound annual growth rate of 40.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.02B | -5.15% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
| May 18, 2016 | 52.40M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |